2000
DOI: 10.1021/jm990580e
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors

Abstract: A series of 4-alkenyl and 4-alkynyl-3, 4-dihydro-4-(trifluoromethyl)-2-(1H)-quinazolinones were found to be potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) of human immunodeficiency virus type-1 (HIV-1). The 4-alkenyl-3, 4-dihydro-4-(trifluoromethyl)-2-(1H)-quinazolinones DPC 082 and DPC 083 and the 4-alkynyl-3, 4-dihydro-4-(trifluoromethyl)-2-(1H)-quinazolinones DPC 961 and DPC 963 were found to exhibit low nanomolar potency toward wild-type RF virus (IC(90) = 2.0, 2.1, 2.0, and 1.3 nM, respec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
107
0
1

Year Published

2006
2006
2013
2013

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 272 publications
(111 citation statements)
references
References 21 publications
3
107
0
1
Order By: Relevance
“…A wide spectrum of pharmacological activities has been reported for these compounds. Some of these therapeutic areas include antimicrobial (Franzen, 2000), anticancer (Lakhan and Rai, 1987;Hour et al, 2000), antiviral (Hamel et al, 1996), anticonvulsant (Corbett et al, 2000;Archana et al, 2003), antifungal (Samir et al, 2007;Bartroli et al, 1998), antiinflammatory (Goel et al, 1999), analgesic (Smith and Dewitt, 1996), and antiproliferative activities (Herschman, 1996;Veeresa et al, 2004). Thiazolidinones derivatives possess broad pharmacological action on the central nervous system, especially anti-HIV agents (Barreca et al, 2001) and cyclooxygenase (COX) inhibitors (Chen et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…A wide spectrum of pharmacological activities has been reported for these compounds. Some of these therapeutic areas include antimicrobial (Franzen, 2000), anticancer (Lakhan and Rai, 1987;Hour et al, 2000), antiviral (Hamel et al, 1996), anticonvulsant (Corbett et al, 2000;Archana et al, 2003), antifungal (Samir et al, 2007;Bartroli et al, 1998), antiinflammatory (Goel et al, 1999), analgesic (Smith and Dewitt, 1996), and antiproliferative activities (Herschman, 1996;Veeresa et al, 2004). Thiazolidinones derivatives possess broad pharmacological action on the central nervous system, especially anti-HIV agents (Barreca et al, 2001) and cyclooxygenase (COX) inhibitors (Chen et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…A wide range of pharmacological activities has been attributed to these molecules. Among these include antimicrobial [5], anticancer [6,7], antiviral [8], anticonvulsant [9,10], antitubercular [11], antifungal [12,13], anti-inflammatory [14], analgesic [15] and antiproliferative [16,17] activities. Thiazolidinone derivatives possess wide range of pharmacological action on central nerves system, especially on anti-HIV agents [18] and cyclooxygenase (COX) inhibitors [19].…”
Section: Introductionmentioning
confidence: 99%
“…Interest in the synthesis of many substituted quinazolinones has been renewed owing to their potential use as physiologically active compounds [16,17] such as antibiotics [18], and potent non-nucleoside reverse transcriptase inhibitors of the human immunodeficiency virus (HIV-1) [19]. A number of synthetic methods for the preparation of substituted (3H)-quinazolin-4-ones have been described [20][21][22][23][24][25].…”
Section: Introductionmentioning
confidence: 99%